The lab of the future elevates diagnostics beyond one physical location and recentralises it around the patient, where acute care is delivered. Respiratory rapid molecular testing at the point-of-care accelerates workflow and improves patient management through real-time diagnosis, reducing overcrowding and promoting cost-effectiveness^1-7. It also strengthens targeted infection control measures and helps prevent spread of disease^1-3,6.

Join this hybrid event, with presentations on site in Stockholm but also streamed live at the same time to learn how rapid molecular testing impacts the laboratory and patient workflow in primary care settings. Our Nordic speakers will discuss the role of rapid molecular diagnostics in their respective setting and how you can utilise this in your own settings, whether it's in the lab or in primary care.